Results 151 to 160 of about 1,230,212 (337)

P980: THE ROLE OF PLATELET AND ENDOTHELIAL MICROPARTICLES AND DOPPLER ULTRASOUND SCREENING IN THE ASSESSMENT OF THROMBOTIC READINESS IN MULTIPLE MYELOMA AND NON HODGKIN LYMPHOMA, PROSPECTIVE STUDY

HemaSphere, 2023
Magdalena Olszewska-Szopa, Urszula Zaleska-Dorobisz, Agnieszka Zubkiewicz-Kucharska, Iwona Prajs, Tomasz Wróbel, Lidia Usnarska-Zubkiewicz   +5 more
doaj   +1 more source

Benign Neoplasms of the Bronchus: With Records of Nine Cases [PDF]

, 1935
H. V. Morlock, A.J. Scott Pinchin
openalex   +1 more source

KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells

Molecular Oncology, EarlyView.
We demonstrate that decitabine (DEC) not only degrades the DNA methyltransferase DNMT1 but also the leukemic driver lysine methyltransferase KMT2A likely due to structural similarity of the DNA‐binding CXXC domains. DEC influences KMT2A downstream processes and synergizes with menin inhibitor revumenib (REV) to decrease leukemic cell proliferation, and
Luisa Brock, Lina Benzien, Sandra Lange, Maja Huehns, Alexandra Runge, Catrin Roolf, Anett Sekora, Gudrun Knuebel, Hugo Murua Escobar, Christian Junghanss, Anna Richter   +10 more
wiley   +1 more source

Large-scale analysis of disease pathways in the human interactome

, 2017
Discovering disease pathways, which can be defined as sets of proteins associated with a given disease, is an important problem that has the potential to provide clinically actionable insights for disease diagnosis, prognosis, and treatment ...
Agrawal, Monica, Leskovec, Jure, Zitnik, Marinka   +2 more
core   +1 more source

Paired organoids from primary gastric cancer and lymphatic metastasis are useful for personalized medicine

Journal of Translational Medicine
Background Organoids are approved by the US FDA as an alternative to animal experiments to guide drug development and for sensitivity screening. Stable organoids models of gastric cancer are desirable for personalized medicine and drug screening. Methods
Ruixin Yang, Yao Qi, Wingyan Kwan, Yutong Du, Ranlin Yan, Lu Zang, Xuexin Yao, Chen Li, Zhenggang Zhu, Xiaoyan Zhang, Hengjun Gao, Io Hong Cheong, Zisis Kozlakidis, Yingyan Yu   +13 more
doaj   +1 more source

STUDIES ON NEOPLASMS WITH THE AID OF RADIOACTIVE PHOSPHORUS. III. THE PHOSPHORUS METABOLISM OF THE PHOSPHOLIPID, ACID SOLUBLE AND NUCLEOPROTEIN FRACTIONS OF VARIOUS TISSUES OF NORMAL AND LEUKEMIC MICE FOLLOWING THE ADMINISTRATION OF “TRACER” AND “THERAPEUTIC” DOSES OF RADIO-PHOSPHORUS1 [PDF]

, 1941
L. W. Tuttle, Lowell A. Erf, John H. Lawrence   +2 more
openalex   +1 more source

Polyfunctional CD8+CD226+RUNX2hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia

Molecular Oncology, EarlyView.
CD226+CD8+ T cells express elevated levels of RUNX2, exhibit higher proliferation capacity, cytokines and cytolytic molecules expression, and migratory capacity. In contrast, CD226−CD8+ T cells display an exhausted phenotype associated with the increased expression of co‐inhibitory receptors and impaired effector functions.
Maryam Rezaeifar, Shima Shahbaz, Anthea C. Peters, Spencer B. Gibson, Shokrollah Elahi   +4 more
wiley   +1 more source

Inhibition of acyl‐CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction

Molecular Oncology, EarlyView.
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy, Heather Fairfield, Victoria E. DeMambro, Samaa Fadel, Carlos A. Gartner, Michelle Karam, Christian Potts, Princess Rodriguez, Ya‐Wei Qiang, Habib Hamidi, Xiangnan Guan, Calvin P. H. Vary, Michaela R. Reagan   +12 more
wiley   +1 more source

Ascites in the Course of Plasma Cell Myeloma Complicated by AL Amyloidosis

Turkish Journal of Hematology, 2018
Jakub Debski, Lidia Usnarska - Zubkiewicz, Katarzyna Kapelko- Slowik, Aleksander Pawlus, Urszula Zaleska - Dorobisz, Kazimierz Kuliczkowski   +5 more
doaj   +1 more source

TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system

Molecular Oncology, EarlyView.
Transient receptor potential melastatin‐4 (TRPM4) is overexpressed in prostate cancer (PCa). Knockout of TRPM4 resulted in reduced PCa tumor spheroid size and decreased PCa tumor spheroid outgrowth. In addition, lack of TRPM4 increased cell death in PCa tumor spheroids.
Florian Bochen, Saurav Subedi, Federico La Manna, Sofia Jarrin, Irida Papapostolou, Marianna Kruithof‐de Julio, Christine Peinelt   +6 more
wiley   +1 more source